🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/04/2019 18,30 18,45 17,84 17,98 -1,96% 3,35% 1.152.600
29/04/2019 19,00 19,07 18,31 18,34 -3,47% 4,00% 1.053.100
26/04/2019 19,09 19,10 18,76 19,00 -0,26% 1,78% 759.400
25/04/2019 18,90 19,17 18,66 19,05 +0,58% 2,70% 812.500
24/04/2019 19,07 19,25 18,63 18,94 -0,68% 3,25% 979.300
23/04/2019 18,64 19,29 18,43 19,07 +2,91% 4,62% 1.225.900
22/04/2019 18,07 18,55 18,03 18,53 +1,98% 2,88% 758.300
18/04/2019 18,32 18,57 17,50 18,17 -1,14% 5,84% 1.373.000
17/04/2019 19,33 19,33 18,00 18,38 -4,52% 6,88% 1.401.500
16/04/2019 18,93 19,42 18,76 19,25 +3,22% 3,49% 1.145.100
15/04/2019 18,47 18,90 18,20 18,65 +1,80% 3,79% 1.149.000
12/04/2019 19,25 19,35 18,12 18,32 -3,83% 6,42% 1.915.100
11/04/2019 19,51 19,63 18,89 19,05 -2,26% 3,79% 1.126.400
10/04/2019 19,25 19,75 19,25 19,49 +1,40% 2,57% 1.080.900
09/04/2019 19,67 19,84 19,18 19,22 -2,68% 3,36% 1.674.100
08/04/2019 19,92 19,98 19,09 19,75 -1,15% 4,47% 1.272.000
05/04/2019 19,42 20,28 19,42 19,98 +3,26% 4,43% 2.042.800
04/04/2019 19,53 19,58 18,87 19,35 -0,72% 3,64% 1.178.300
03/04/2019 19,00 19,66 18,80 19,49 +3,78% 4,53% 1.559.000
02/04/2019 18,29 18,87 18,21 18,78 +2,62% 3,61% 1.163.800
01/04/2019 18,54 18,87 18,15 18,30 -0,27% 3,91% 1.219.100
29/03/2019 18,33 18,45 18,01 18,35 +1,44% 2,42% 1.101.400
28/03/2019 17,78 18,19 17,70 18,09 +1,86% 2,76% 1.000.800
27/03/2019 18,40 18,45 17,56 17,76 -3,58% 4,84% 1.396.500
26/03/2019 18,27 18,53 18,16 18,42 +1,94% 2,03% 1.109.100
25/03/2019 17,71 18,20 17,27 18,07 +1,69% 5,25% 1.542.900
22/03/2019 18,96 19,25 17,77 17,77 -6,82% 7,81% 1.632.300
21/03/2019 18,33 19,19 18,27 19,07 +2,86% 5,02% 1.117.500
20/03/2019 18,79 19,00 18,27 18,54 -1,54% 3,89% 897.400
19/03/2019 18,94 19,03 18,54 18,83 -0,26% 2,59% 1.162.400